Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Kala Pharmaceuticals Inc. buy LADENBURG THALM/SH SH

Start price
€5.16
11.07.25 / 50%
Target price
€10.28
11.07.26
Performance (%)
-98.70%
End price
-
12.07.26
Summary
This prediction is currently being closed. Massive losses of -98.70% have been the result for the BUY prediction by LADENBURG_THALM_SH_S. LADENBURG_THALM_SH_S has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Kala Pharmaceuticals Inc. - - -
iShares Core DAX® -1,59 % 5,03 % 6,33 %
iShares Nasdaq 100 -4,15 % -0,13 % 25,73 %
iShares Nikkei 225® -6,30 % 0,53 % 41,38 %
iShares S&P 500 -3,23 % 0,47 % 20,45 %

Comments by LADENBURG_THALM_SH_S for this prediction

In the thread Kala Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) -98.70%
Target price 10.278
Change
Ends at 11.07.26

KALA BIO, Inc. (NASDAQ: KALA) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $12.00 price target on the stock.
Ratings data for KALA provided by MarketBeat

In the thread Trading Kala Pharmaceuticals Inc.
Prediction Buy
Perf. (%) -98.70%
Target price 10.278
Change
Ends at 11.07.26

Die von LADENBURG_THALM_SH_S gewählte maximale Laufzeit wurde überschritten